IDEAYA Biosciences (IDYA) Enterprise Value (2019 - 2025)
IDEAYA Biosciences (IDYA) has disclosed Enterprise Value for 7 consecutive years, with -$639.4 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 5.46% to -$639.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$639.4 million through Dec 2025, up 5.46% year-over-year, with the annual reading at -$639.4 million for FY2025, 5.46% up from the prior year.
- Enterprise Value hit -$639.4 million in Q4 2025 for IDEAYA Biosciences, up from -$786.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$246.8 million in Q4 2021 to a low of -$920.0 million in Q3 2024.
- Historically, Enterprise Value has averaged -$498.6 million across 5 years, with a median of -$481.2 million in 2023.
- Biggest five-year swings in Enterprise Value: tumbled 244.08% in 2021 and later grew 16.45% in 2022.
- Year by year, Enterprise Value stood at -$246.8 million in 2021, then tumbled by 47.84% to -$364.8 million in 2022, then crashed by 43.93% to -$525.1 million in 2023, then dropped by 28.79% to -$676.3 million in 2024, then increased by 5.46% to -$639.4 million in 2025.
- Business Quant data shows Enterprise Value for IDYA at -$639.4 million in Q4 2025, -$786.9 million in Q3 2025, and -$669.7 million in Q2 2025.